ZEQWAL
DEAD

Serial Number

86203702

Owner

GLAXO GROUP LIMITED

Attorney

Christopher M. Hanes

Filing Date

Feb 25, 2014

Add to watchlist:

No watchlists yet
View on USPTO

ZEQWAL Trademark

Serial Number: 86203702

ZEQWAL is a trademark filed by GLAXO GROUP LIMITED on February 25, 2014. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

GLAXO GROUP LIMITED (5,077 trademarks)

980 Great West Road
Brentford, Middlesex TW89GS , GB

Entity Type: 03

Trademark Details

Filing Date

February 25, 2014

Registration Date

Not Registered

Goods & Services

(Based on Intent to Use) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(d) Priority Application) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(e)) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Filing History

ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Dec 30, 2014 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Dec 30, 2014 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 3, 2014 GNRN
NON-FINAL ACTION E-MAILED
Jun 3, 2014 GNRT
NON-FINAL ACTION WRITTEN
Jun 3, 2014 CNRT
ASSIGNED TO EXAMINER
Jun 2, 2014 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 10, 2014 NWOS
NEW APPLICATION ENTERED
Feb 28, 2014 NWAP